We are live on ! Find out more
ALVO icon

Alvotech

53 hedge funds and large institutions have $156M invested in Alvotech in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

4% more funds holding

Funds holding: 5153 (+2)

0.05% more ownership

Funds ownership: 5.53%5.58% (+0.05%)

2% less capital invested

Capital invested by funds: $159M → $156M (-$3.25M)

11% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 19

Holders
53
Holders Change
+2
Holders Change %
+3.92%
% of All Funds
0.7%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
7
Increased
17
Reduced
19
Closed
5
Calls
Puts
Net Calls
Net Calls Change

ALVO Hedge Fund Activity: Q2 2025 in Review

53 of the 7,614 institutional investors tracked by Wall St. Rank reported a position in Alvotech (ALVO) for Q2 2025, worth a combined $156M — down 2% from $159M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ALVO positions and 5 closed out — a net gain of 2 holders — while 17 added to existing stakes and 19 trimmed.

The largest buyer was Heights Capital Management, opening a new position worth an estimated $10.2M. The largest seller was Morgan Stanley, cutting an estimated $6.15M.

  • 53 institutional investors held Alvotech (ALVO) as of Q2 2025, up from 51 in Q1 2025.
  • Funds reported $156M of Alvotech stock for Q2 2025, down 2% quarter-over-quarter.
  • 7 funds opened new Alvotech positions in Q2 2025 and 5 closed out, a net change of +2 holders.
  • The largest Alvotech buyer in Q2 2025 was Heights Capital Management, an estimated $10.2M added.
  • The largest Alvotech seller in Q2 2025 was Morgan Stanley, an estimated $6.15M sold.

Based on aggregated 13F filings for Q2 2025.